Fang Yuan is the founder of Weikaier Pharmaceutical Technology. Weikaier Pharmaceutical Technology has raised $63M in total funding. Latest round: Series C.
Fang Yuan is the founder of Weikaier Pharmaceutical Technology. Her company focuses on the research and development of small molecule innovative targeted drugs, with a commitment to source innovation and self-research in areas such as autoimmune diseases and chronic inflammatory diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library